Completed

Acupuncture for Pain and Dysfunction Following Neck Dissection: A Randomized, Controlled, Phase III Trial

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

acupuncture therapy

+ standard follow-up care

Procedure
Who is being recruted

Head and Neck Neoplasms

+ Neoplasms

+ Neoplasms by Site

See all eligibility criteria
How is the trial designed

Supportive Care Study

Phase 3
Interventional
Study Start: November 2003
See protocol details

Summary

Principal SponsorMemorial Sloan Kettering Cancer Center
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: November 1, 2003

Actual date on which the first participant was enrolled.

OBJECTIVES: Primary * Determine whether acupuncture reduces pain and dysfunction in patients with head and neck cancer who have undergone neck dissection. Secondary * Determine whether acupuncture relieves dry mouth in these patients. OUTLINE: This is a randomized, controlled study. Patients are stratified according to surgical procedure (selective neck dissection vs modified radical neck dissection vs radical neck dissection) and baseline Constant-Murley score (≤ 35 vs > 35). Patients are randomized into 1 of 2 treatment arms. * Arm I: Patients undergo acupuncture for 20-30 minutes once weekly for 4 weeks. * Arm II: Patients undergo standard of care for 4 weeks. In both arms, treatment continues in the absence of unacceptable toxicity. The Constant-Murley score is assessed at baseline and then at week 6. Pain medication use is recorded at baseline, during study treatment, and then at week 6. Numerical Rating Scale of pain on activity and xerostomia inventories are completed at baseline and then at weeks 5 and 6. After completion of study treatment, patients are followed periodically. PROJECTED ACCRUAL: A total of 58 patients will be accrued for this study.

Official TitleAcupuncture for Pain and Dysfunction Following Neck Dissection: A Randomized, Controlled, Phase III Trial 
NCT00090337
Principal SponsorMemorial Sloan Kettering Cancer Center
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

73 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Head and Neck NeoplasmsNeoplasmsNeoplasms by Site

Criteria

DISEASE CHARACTERISTICS: * Must have undergone neck dissection for cancer ≥ 3 months ago (in order to qualify pain as chronic sequella) * Subjective complaint of pain and/or dysfunction in the neck and/or shoulders that, in the opinion of the investigator, is due to neck dissection * Constant-Murley score ≤ 70 (i.e., moderate or severe pain and dysfunction) * No moderate or severe neck or shoulder pain that, in the opinion of the investigator, is not due to cancer surgery PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * See Disease Characteristics * At least 3 months since prior radiotherapy * More than 6 weeks since prior acupuncture * Concurrent analgesics allowed

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients undergo acupuncture for 20-30 minutes once weekly for 4 weeks.

Group II

Active Comparator
Patients undergo standard of care for 4 weeks.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Memorial Sloan - Kettering Cancer Center

New York, United StatesSee the location
CompletedOne Study Center